Screening for type 2 diabetes and hypertension in seafarers' medical examinations.

early diagnosis fishermen hypertension metabolic syndrome screening seafarers type 2 diabetes

Journal

International maritime health
ISSN: 2081-3252
Titre abrégé: Int Marit Health
Pays: Poland
ID NLM: 100958373

Informations de publication

Date de publication:
2022
Historique:
received: 12 05 2022
accepted: 22 06 2022
entrez: 5 7 2022
pubmed: 6 7 2022
medline: 8 7 2022
Statut: ppublish

Résumé

The aims of the study are: 1) to replace the urine glucose test for diabetes with more than 50% false negatives, with an accurate screening for type 2 diabetes and hypertension in the mandatory biannual fit-for-duty medical examinations of seafarers; 2) to produce data driven "Green Ship" health pro-motion in the ships. A new health promotion and disease prevention public health intervention programme integrated in the fit-for-duty medical examinations for seafarers is being developed. The lack of an accurate diagnosis of type 2 diabetes is replaced by accurate HbA1c and/or fasting glucose tests and the test for hypertension in various disease stages is based on the International Associations' Guidelines. A "Green Ship" health promotion programme is proposed for all on board, not only for diseased crew members. A protocol for an accurate biannual screening for diabetes and hypertension is presented. Educational programmes for medical doctors and seafarers on the management of hypertension and diabetes on board will be developed. Presuming that all crew members are potentially on their way to be pre-diseased or are diseased, the "Green Ship" health promotion programme is implemented for the whole crew. The International Labour Organization and the National Maritime Authorities are prompted to revise the International and the National Guidelines for Seafarers Medical Examinations, respectively. Con-certed actions are requested to implement public health promotion projects in shipping. Maritime medical doctors are prompted to use health dialogues and to report the clinical data in the Excel file. Sustainability is obtained by complying with the Sustainable Development Goals (3, 4, 8, 10, and 17).

Sections du résumé

BACKGROUND
The aims of the study are: 1) to replace the urine glucose test for diabetes with more than 50% false negatives, with an accurate screening for type 2 diabetes and hypertension in the mandatory biannual fit-for-duty medical examinations of seafarers; 2) to produce data driven "Green Ship" health pro-motion in the ships. A new health promotion and disease prevention public health intervention programme integrated in the fit-for-duty medical examinations for seafarers is being developed.
MATERIALS AND METHODS
The lack of an accurate diagnosis of type 2 diabetes is replaced by accurate HbA1c and/or fasting glucose tests and the test for hypertension in various disease stages is based on the International Associations' Guidelines. A "Green Ship" health promotion programme is proposed for all on board, not only for diseased crew members.
RESULTS
A protocol for an accurate biannual screening for diabetes and hypertension is presented. Educational programmes for medical doctors and seafarers on the management of hypertension and diabetes on board will be developed. Presuming that all crew members are potentially on their way to be pre-diseased or are diseased, the "Green Ship" health promotion programme is implemented for the whole crew.
CONCLUSIONS
The International Labour Organization and the National Maritime Authorities are prompted to revise the International and the National Guidelines for Seafarers Medical Examinations, respectively. Con-certed actions are requested to implement public health promotion projects in shipping. Maritime medical doctors are prompted to use health dialogues and to report the clinical data in the Excel file. Sustainability is obtained by complying with the Sustainable Development Goals (3, 4, 8, 10, and 17).

Identifiants

pubmed: 35781681
pii: VM/OJS/J/90053
doi: 10.5603/IMH.2022.0010
doi:

Substances chimiques

Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

64-72

Auteurs

Olaf Chresten Jensen (OC)

Centre for Maritime Health and Society, Department of Public Health, Southern Danish University, Esbjerg, Denmark. ocj@health.sdu.dk.

Agnes Flores (A)

Universidad Metropolitana de Educación Ciencia y Tecnología, Facultad de las Ciencias y Tecnología, Panama.
Caja Seguro Social, Rep. of Panamá, Vacamonte, Panama.

Victoria Corman (V)

Centre for Maritime Health and Society, Department of Public Health, Southern Danish University, Esbjerg, Denmark.
Department of Public Health, University of Southern Denmark, Esbjerg, Denmark.

Maria Luisa Canals (ML)

University of Cadiz FUECA, Sociedad Española de Medicina Marítima (SEMM)/Sanidad Marítima, Tarragona, Spain.

David Lucas (D)

French Society for Maritime Medicine, Brest, France.
Faculty of Medicine and Health Sciences, University of Western Brittany, Brest, France.

Ilona Denisenko (I)

Regional Medical Office German Embassy Moscow, Russian Federation.

Don Eliseo-Iii Lucero-Prisno (DE)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Faculty of Management and Development Studies, University of the Philippines Open University, Los Baños, Laguna, Philippines.

Anna Lilja Secher (AL)

Clinical Research, Steno Diabetes Centre Copenhagen, Denmark.

Gregers Stig Andersen (GS)

Clinical Research, Steno Diabetes Centre Copenhagen, Denmark.

Marit Eika Jørgensen (ME)

Clinical Research, Steno Diabetes Centre Greenland, Greenland.

Helena Estopà Pujol (HE)

Sanidad Marítima (ISM), Barcelona, Spain.

Guido Cohen (G)

Faculty of Medicine, Panama University, Rep. of Panama, Panama.

Finn Gyntelberg (F)

National Research Centre for Work Environment, Occupational Medicine Clinic, Bispebjerg Hospital, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH